The Centers for Disease Control and Prevention has issued updated guidance for who can get a second booster dose of an mRNA COVID-19 vaccine. The guidance includes the following groups who received their first booster dose at least 4 months ago: People 50 and older People 12 and older who are moderately to severely immunocompromised People 18 to…
Read More
If you’ve had any new or lasting symptoms since recovering from COVID-19, you may have what doctors call “post-acute sequelae of COVID-19 (PASC),” or “post-COVID conditions.” Also known as “long COVID,” it can include a range of symptoms that continue after the initial COVID-19 illness ends. How do you know if you have long-term COVID-19?…
Read More
Latest update on Omicron variantKaiser Permanente is closely monitoring the Omicron variant, and continues to learn about its transmission rate or whether it causes more severe illness. Current vaccines are expected to protect against severe illness, hospitalizations, and deaths due to infection with the Omicron variant. However, breakthrough infections in people who are fully vaccinated…
Read More
Is the Omicron variant contagious? The Omicron variant spreads more faster than the other variants. What are the Omicron variant symptoms? There is no information to suggest that Omicron causes different COVID-19 symptoms from other COVID-19 variants. How severe is the Omicron variant? Early findings suggest that Omicron is less severe than the Delta variant.…
Read More
On November 23, Kaiser Permanente informs the public that the CDC’s Advisory Committee on Immunization Practices (ACIP) has recommended booster doses of the Moderna and Pfizer COVID-19 vaccines for all adults 18 years and older in alignment with the FDA’s expansion of the emergency use authorization for both vaccines. For those who received their primary…
Read More
On September 26, Kaiser Permanente informs the public that the Centers for Disease Control and Prevention (CDC) has recommended the Pfizer COVID-19 vaccine for children 5 to 11. The Pfizer vaccine for children comes in a lower dose and with smaller needles than those used for people 12 and older. Like the vaccine for adults…
Read More
On September 26, Kaiser Permanente informs the public that the Centers for Disease Control and Prevention (CDC) recommends booster doses of the Moderna and Johnson & Johnson COVID-19 vaccines for certain groups. Moderna: For people who received two doses of the Moderna vaccine at least six months ago, the committee recommended a booster dose for: People 65 or…
Read More
On September 24, Kaiser Permanente informs the public that the Centers for Disease Control and Prevention (CDC) recommends that a Pfizer booster dose should be administered at least six months after completion of the Pfizer primary series for: People 65 or older Long term care facility residents People 50 through 64 with underlying medical conditions On the…
Read More
Is the Delta variant contagious? The Delta variant is highly contagious, nearly twice as contagious as previous variants. What are the Delta variant symptoms? Delta variant symptoms are the same as other versions of COVID-19. Am I at risk for the Delta variant? Unvaccinated people remain the greatest concern Does the COVID-19 vaccine protect against the…
Read More
Kaiser Permanente has resumed use of the Johnson & Johnson COVID-19 vaccine, as availability requires, this is in response to the recommendation of the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), and …
Read More